Authors
Latest:
Concluding Remarks: Systemic Treatment Considerations for Atopic Dermatitis in Patients of Childbearing PotentialLooking to the future of atopic dermatitis treatment, Drs Kiracofe and Murase offer concluding remarks on current unmet needs, the benefits of treatment guidelines, and the importance of treating itch in patients who are or may become pregnant.
Latest:
Q&A: How the PWRS Program and Inaugural Report is Empowering Women and Transforming Global HealthcareEve Arnera and Thandiwe Munaiwa, MD, spoke about the groundbreaking collaboration between SkinCeuticals and ReSurge International, “Pioneering Women in Reconstructive Surgery.”
Latest:
Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell CarcinomaExperts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.
Latest:
Topical Ruxolitinib in Vitiligo: Efficacy, Regional Approvals, and Treatment Strategies in African American PatientsDr. Latanya Benjamin, MD, FAAD, FAAP, discusses the role of topical ruxolitinib cream in managing vitiligo and its effectiveness in a 25-year-old female patient.
Latest:
Lasers' Role in Broadening the Pediatric ToolboxDeepti Gupta, MD, discussed the importance of lasers at the Society for Pediatric Dermatology 37th Annual Pre-AAD Annual Meeting.
Latest:
Rare Overlap of 2 Autoinflammatory Keratinization Diseases Observed in Single LesionA case study explores a rare overlap of hidradenitis suppurativa and porokeratosis, highlighting unique histopathology and complications.
Latest:
Temtokibart Demonstrates Efficacy in Adults With Moderate to Severe Atopic DermatitisLEO Pharma reveals promising phase 2b trial results for temtokibart, a treatment targeting moderate to severe atopic dermatitis effectively.
Latest:
Stopping Adjuvant Immunotherapy Early May Not Worsen Outcomes in Resected Metastatic MelanomaNew research reveals that early discontinuation of adjuvant immunotherapy for melanoma does not lead to worse outcomes.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
AAD is More Than Just a ConferenceNeal Bhatia, MD, shares his insights on successfully navigating AAD and his session highlights on office politics.
Latest:
KT-474 Demonstrates Efficacy and Promise in Atopic Dermatitis and Hidradenitis Suppurativa StudyJared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.
Latest:
Psoriasis Case ImpressionsMark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.
Latest:
Psychological Effects of Cosmetic Procedures Extend Far Beneath the SurfaceUnderstanding the underlying motivation for seeking out minimally invasive cosmetic procedures is important to provide individualized and holistic care to patients.
Latest:
Potential Role of AI in HS DiagnosisPanelists discuss how the role of AI in Hidradenitis Suppurativa and the potential for complex multi-input factors.
Latest:
What Lies Ahead for GPP Diagnosis and ManagementPanelists discuss how the future of generalized pustular psoriasis (GPP) diagnosis and management looks promising with emerging genetic testing for IL36RN mutations, development of multiple targeted biologics beyond IL-36 inhibitors, potential personalized treatment algorithms, improved disease classification, and enhanced multidisciplinary care approaches to better address this rare but severe dermatological condition.
Latest:
Malignancy Risk Low in Secukinumab TreatmentA study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.
Latest:
Spotlighting Biologic Advancements and Novel Pathways in Atopic DermatitisAt RAD 2025, Jonathan Silverberg, MD, PhD, MPH, provided an in-depth look at the clinical integration of newly approved biologics nemolizumab and lebrikizumab in AD.
Latest:
Strategies for Integrating Advanced Skincare Technologies: Ensuring Evidence-Based PracticeSaranya Wyles, MD, PhD, offers guidance on integrating advanced skincare technologies into their practices and the importance of staying updated through events like the Science of Skincare summit.
Latest:
Harnessing the Potential of Placental AllograftsPlacental tissues provide a promising alternative for addressing cutaneous reconstruction while maintaining the most cosmetically pleasing outcome.
Latest:
Continuing Medical Education: Three Things to Know About Pustular PsoriasisPustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.
Latest:
3 Things You Should Know About HS Pathology and ManagementEarn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in KidsPaller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Latest:
Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care BrandShah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
The Importance of Collaboration Between Mohs Surgeons and UrologistsCaleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
